$120 Million is the total value of Antipodean Advisors LLC's 12 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVNA | Buy | CARVANA COcl a | $23,760,000 | +13.3% | 360,000 | +7.5% | 19.82% | -22.3% |
| CDLX | Buy | CARDLYTICS INC | $21,788,000 | +489.2% | 650,000 | +356.6% | 18.17% | +304.0% |
| CLVT | Buy | CLARIVATE ANALYTICS PLC | $19,822,000 | +17.2% | 1,175,000 | +6.8% | 16.53% | -19.7% |
| SE | Buy | SEA LTDsponsored ads | $17,023,000 | +64.8% | 550,000 | +76.8% | 14.20% | +13.0% |
| MDCO | Buy | MEDICINES CO | $16,050,000 | +71.2% | 321,000 | +24.9% | 13.39% | +17.4% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $9,351,000 | +36.7% | 247,000 | +54.4% | 7.80% | -6.3% |
| AMZN | AMAZON COM INC | $6,336,000 | -8.3% | 3,650 | 0.0% | 5.28% | -37.1% | |
| HOME | New | AT HOME GROUP INC | $4,089,000 | – | 425,000 | +100.0% | 3.41% | – |
| CCXU | CHURCHILL CAP CORP IIunit 99/99/9999 | $1,051,000 | +3.5% | 100,000 | 0.0% | 0.88% | -29.0% | |
| DEACU | DIAMOND EAGLE ACQUISITION COunit 06/30/2026 | $254,000 | +0.8% | 25,000 | 0.0% | 0.21% | -30.9% | |
| OACU | New | OAKTREE ACQUISITION CORPunit 99/99/9999 | $203,000 | – | 20,000 | +100.0% | 0.17% | – |
| RPLAU | New | REPLAY ACQUISITION CORPunit 03/01/2024 | $159,000 | – | 15,500 | +100.0% | 0.13% | – |
| RPLA | Exit | REPLAY ACQUISITION CORP | $0 | – | -15,500 | -100.0% | -0.19% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -3,000 | -100.0% | -0.43% | – |
| LYFT | Exit | LYFT INC | $0 | – | -21,000 | -100.0% | -1.68% | – |
| CMCSA | Exit | COMCAST CORP NEWcl a | $0 | – | -95,000 | -100.0% | -4.89% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARVANA CO | 21 | Q2 2023 | 38.5% |
| AMAZON COM INC | 20 | Q4 2020 | 33.8% |
| SEA LTD | 19 | Q3 2023 | 60.8% |
| CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
| MEDICINES CO | 18 | Q4 2019 | 19.8% |
| ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
| CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
| HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
| CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
| EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.